CA-GLOBALLOGIC
11.5.2022 14:02:10 CEST | Business Wire | Press release
GlobalLogic Inc. , a Hitachi Group company and leader in Digital Engineering, has launched the Women Influencers Program, designed to encourage and enable women employees interested in exploring cross-functional management positions within the technology firm. As part of the company’s focus on DEI (Diversity, Equity, Inclusion), GlobalLogic is aiming for greater diversity at all levels in the workforce across gender, sexual orientation, color, ethnic origin, age and ability. The Women Influencers Program is specifically focused to promote greater gender diversity especially among the company’s leadership ranks. The Program will provide developmental and mentoring opportunities through GlobalLogic’s People Development function and individual business units.
Core Program Elements
The Program centers around nine competencies that participants will explore via a set of learning modules, with an entire Program journey expected to last five to six months. Operating in tandem, global cohorts of women based across the globe will join together to share and learn from collective experiences.
The competencies promote the development of “soft” skills – meaning those not directly tied to a formal educational program but rather gained through experience and from peers. These competencies include directness and candor, inspiring and influencing others, effective decision making, professional network development, and the continued development of communication skills. Program participants will also receive training specific to GlobalLogic’s capabilities which are meant to enhance essential corporate knowledge and increase depth of technical competencies.
"Diversity, equity, and inclusion are paramount to GlobalLogic's success," said Amy Hanlon-Rodemich, Chief People Officer, GlobalLogic. "We created the Women Influencers Program to elevate emerging women leaders and to prepare them to take on a wider range of roles and responsibilities including expansion into senior leadership roles. This Program will enable more women leaders to take on more strategic positions within the company."
Based on Research
Initially piloted in India in 2020, the Program’s intent was to actively focus on enhancing the company’s management pipeline with a consideration toward diversity and inclusivity; particularly for women within the company. Upon conducting in-depth analysis of leadership roles and paths to those positions, GlobalLogic’s Program development team discovered that while the digital engineering firm’s overall diversity stats were above the industry average, an even more diverse senior management team would be a tremendous enhancement to the current management ranks.
Research suggests that the female-to-male disparity is due to multiple factors, including prioritization of personal and family life, cultural demands and differences, and organizational dynamics. It was also noted that many women express a distinct “burn out” effect, indicating an ongoing struggle to identify resources and opportunities for progressing their careers.
In response, the Program development team explored options for accelerating women’s career paths by developing essential leadership skills and helping them becoming future ready, positioning participants to take on new roles within GlobalLogic.
“Our aim is to correct the imbalance in women holding leadership roles versus men, which is common throughout the technology industry according to global statistics,” said Shivani Khanna, Senior Manager, People Team, GlobalLogic. “We believe that through our Program’s structured guidance and encouragement, we can positively shift that dynamic.”
Establishing a Supportive Ecosystem
The ecosystem being developed by GlobalLogic will include “Anchors,” a role held by members of the human resources team who will help ensure that the Program is operating effectively. Anchors will also manage the learning and mentor groups that will spearhead the specific activities designed to provide the professional skills previously referenced.
Participants’ managers will be enlisted as “Program Catalysts” responsible for ensuring that the Program is not simply a training exercise but rather a complete learning journey championing employee learning and advancement across the organization.
“Program Sponsors — the managers and mentors — will act as coaches overseeing the employees’ journeys. They will help steer participants toward the content and activities appropriate to each individual’s unique path,” Khanna continued. “We’re excited to officially launch this Program in GlobalLogic locations around the world.”
About GlobalLogic
GlobalLogic (www.globallogic.com ) is a leader in digital engineering. We help brands across the globe design and build innovative products, platforms, and digital experiences for the modern world. By integrating experience design, complex engineering, and data expertise – we help our clients imagine what’s possible and accelerate their transition into tomorrow’s digital businesses. Headquartered in Silicon Valley, GlobalLogic operates design studios and engineering centers around the world, extending our deep expertise to customers in the automotive, communications, financial services, healthcare and life sciences, manufacturing, media and entertainment, semiconductor, and technology industries. GlobalLogic is a Hitachi Group Company operating under Hitachi, Ltd. (TSE: 6501), which contributes to a sustainable society with a higher quality of life by driving innovation through data and technology as the Social Innovation Business.
GlobalLogic is a trademark of GlobalLogic. All other brands, products or service names are or may be trademarks or service marks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220511005037/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
